A Phase 1 Study to Evaluate PK, Safety and Tolerability of AMG 416
Clinical trial NCT03283098 · COMPLETED
Trial details
- NCT number
- NCT03283098
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-01
- Primary completion
- 2019-02-04
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.